.
MergerLinks Header Logo

Announced

DCC to acquire Ion Laboratories for $60m.

Financials

Edit Data
Transaction Value£46m
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales0.7x
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

specialty pharma

Acquisition

United States

Friendly

Pharmaceuticals

Single Bidder

Private

Pending

Majority

Synopsis

Edit

DCC Health and Beauty Solutions, a manufacturer of nutritional, cosmetic and pharmaceutical products, agreed to acquire Ion Laboratories, a provider of contract manufacturing and related services to the growing health supplements and nutritional products market in the US, for $60m. "DCC Health & Beauty Solutions provides high-quality services to leading health and beauty brand owners, specialist retailers, and direct sales organizations. The acquisition of Ion significantly enhances our presence in the US market, and Ion will work closely with both Elite One Source and DCC Health & Beauty Solutions' European businesses to cross-sell the full breadth of the Group's comprehensive offering for health & beauty brands," Donal Murphy, DCC Chief Executive.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US